Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Acromegaly and GHR[original query] |
---|
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Human genetics 2006 Jun 119 (5): 527-40. Horan Martin, Newsway Vicky, Yasmin , Lewis Mark D, Easter Tammy E, Rees D Aled, Mahto Arti, Millar David S, Procter Annie M, Scanlon Maurice F, Wilkinson Ian B, Hall Ian P, Wheatley Amanda, Blakey John, Bath Philip M W, Cockcroft John R, Krawczak Michael, Cooper David |
Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clinical chemistry 2007 Aug 53 (8): 1484-8. Schmid Christoph, Krayenbuehl Pierre-Alexandre, Bernays René-Ludwig, Zwimpfer Cornelia, Maly Friedrich E, Wiesli Pet |
Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. The Journal of clinical endocrinology and metabolism 2008 Sep 93 (9): 3411-5. Mercado Moisés, González Baldomero, Sandoval Carolina, Esquenazi Yoshua, Mier Fernando, Vargas Guadalupe, de los Monteros Ana Laura Espinosa, Sosa Ernes |
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. Pituitary 2009 12 (3): 196-9. Bianchi Antonio, Mazziotti Gherardo, Tilaro Laura, Cimino Vincenzo, Veltri Flora, Gaetani Eleonora, Pecorini Giovanni, Pontecorvi Alfredo, Giustina Andrea, De Marinis Lau |
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. European journal of endocrinology / European Federation of Endocrine Societies 2009 Aug 161 (2): 231-5. Kamenicky Peter, Dos Santos Christine, Espinosa Consuelo, Salenave Sylvie, Galland Françoise, Le Bouc Yves, Maison Patrick, Bougnères Pierre, Chanson Philip |
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. The Journal of clinical endocrinology and metabolism 2009 Jun 94 (6): 2015-22. Bianchi Antonio, Giustina Andrea, Cimino Vincenzo, Pola Roberto, Angelini Flavia, Pontecorvi Alfredo, De Marinis Lau |
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly. The Journal of clinical endocrinology and metabolism 2010 Jan 95 (1): 222-9. Bernabeu Ignacio, Alvarez-Escolá Cristina, Quinteiro Celsa, Lucas Tomás, Puig-Domingo Manel, Luque-Ramírez Manuel, de Miguel-Novoa Paz, Fernandez-Rodriguez Eva, Halperin Irene, Loidi Lourdes, Casanueva Felipe F, Marazuela Móni |
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype. Clinical endocrinology 2010 May 72 (5): 661-7. Montefusco Laura, Filopanti Marcello, Ronchi Cristina L, Olgiati Luca, La-Porta Carmen, Losa Marco, Epaminonda Paolo, Coletti Francesca, Beck-Peccoz Paolo, Spada Anna, Lania Andrea G, Arosio Mau |
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study. The Journal of clinical endocrinology and metabolism 2012 Feb 97 (2): E165-72. Filopanti M, Olgiati L, Mantovani G, Corbetta S, Arosio M, Gasco V, De Marinis L, Martini C, Bogazzi F, Cannavò S, Colao A, Ferone D, Arnaldi G, Pigliaru F, Peri A, Angeletti G, Jaffrain-Rea M L, Lania A G, Spada |
Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values? General and comparative endocrinology 2013 Jul 188 282-7. Kohler S, Tschopp O, Sze L, Neidert M, Bernays R-L, Spanaus K-S, Wiesli P, Schmid |
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. European journal of endocrinology / European Federation of Endocrine Societies 2013 Jan . Larkin SJ, Reddy RG, Karavitaki N, Cudlip S, Wass JA, Ansorge O |
The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly. Pituitary 2015 Feb 18 (1): 116-25. Cinar Nese, Dagdelen Selcuk, Yorgun Hikmet, Canpolat Ugur, Kabakç? Giray, Erbas Tomr |
Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3. European journal of endocrinology / European Federation of Endocrine Societies 2015 Aug . Franck Sanne Elisabeth, Van der Lely A J, Delhanty Patric J, Jorgensen Jens Otto L, Neggers Sebastian J C M |
Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly. Endocrinology and metabolism (Seoul, Korea) 2015 Jan . Park Hye Yoon, Hwang In Ryang, Seo Jung Bum, Kim Su Won, Seo Hyun Ae, Lee In Kyu, Kim Jung G |
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary 2015 Oct 18 (5): 666-73. Jallad Raquel S, Trarbach Ericka B, Duarte Felipe H, Jorge Alexander A L, Bronstein Marcello |
The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis. Neuroendocrinology 2016 Aug . Franck Sanne E, Broer Linda, van der Lely Aart Jan, Kamenicky Peter, Bernabéu Ignacio, Malchiodi Elena, Delhanty Patric J D, Rivadeneira Fernando, Neggers Sebastian J C M |
Growth hormone receptor exon 3 isoforms may have no importance in the clinical setting of multiethnic Brazilian acromegaly patients. Pituitary 2016 Mar . de Oliveira Machado Evelyn, Lima Carlos Henrique Azeredo, Ogino Liana Lumi, Kasuki Leandro, Gadelha Mônica |
Serum leptin levels and GHR-d3/fl gene polymorphism in acromegalic patients with thyroid nodules. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 0 26 (2): 281-286. Topsakal Senay, Akin Fulya, Turgut Sabahat, Yerlikaya Emrah, Yaylali Guzin |
Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly. Journal of endocrinological investigation 2019 8 43 (2): 163-171. Pontes J, Madeira M, Lima C H A, Ogino L L, de Paula Paranhos Neto F, de Mendonça L M C, Farias M L F, Kasuki L, Gadelha M |
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study. Frontiers in endocrinology 2024 9 15 1414101. Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Flavia Angelini, Consolato Gullì, Liverana Lauretti, Mario Rigante, Alessandro Olivi, Laura De Marinis, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecor |
The Role of the GH Receptor Polymorphisms as a Prognostic Factor of Vertebral Fractures in Acromegalic Patients Resistant to First-generation SSAs and Treated with Pegvisomant or Pasireotide LAR. Endocrine, metabolic & immune disorders drug targets 2024 7 . Flavia Costanza, Sabrina Chiloiro, Antonella Giampietro, Flavia Angelini, Amato Infante, Alfredo Pontecorvi, Laura De Marinis, Antonio Bianc |
- Page last reviewed:Feb 1, 2024
- Content source: